Weekly Digest - June 2025
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
Weekly Digest - June 2025
06 June 2025: OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMine Enabling Technologies
- OBI Pharma and TegMine Therapeutics have entered a Master Services Agreement to collaborate on developing novel ADCs using OBI’s GlycOBI® technology and TegMine’s antibody expertise targeting cancer glycans
- TegMine will utilize OBI’s proprietary ADC-enabling platforms EndoSymeOBI® and HYPrOBI® to identify potential clinical ADC candidates
- If promising ADCs emerge, both companies plan to enter a formal licensing agreement to advance them toward clinical development
